A Phase II Trial of Olaparib and Durvalumab in Patients with Recurrent IDH-mutated Gliomas.Xin Wang,Yosef Ellenbogen,Christianne Mojica, Gustavo Duarte Ramos Matos,Roa Alsajjan,Ronald Ramos,Seth Andrew Climans,Mathew Voisin,Vikas Patil, Stephanie Baker, Yin-Ling Chan,Thiago Pimentel Muniz,Andrew Gao,Ben X. Wang,Gelareh Zadeh,Warren P. Mason,Eric Xueyu ChenJOURNAL OF CLINICAL ONCOLOGY（2024）引用 5|浏览27暂无评分关键词IDH Mutation,PARP InhibitorsAI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
